Thus, strategies for up-regulating protein expression or augmenting the activity of parkin/pink1/DJ-1 pathway might provide useful therapeutic approaches for neurodegenerative complications, such as diabetes and PD [65,66]. The gene discussed is PARK7; the disease is diabetes mellitus.